Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Precision medicine

Outside the Lab Digital and computational pathology

Intelligent Pharma Partners

| Holger Lange and Cris Luengo

How combining their efforts with those of the pharmaceutical industry can help pathologists make a business case for AI

Outside the Lab Biochemistry and molecular biology

Fighting Resistance in Bloodstream Infections

| Luke Turner

When bacteria become resistant to the last line of defense, rapid detection and treatment is more important than ever. A new assay can help with treatment selection for carbapenem-resistant infections

Inside the Lab Companion diagnostics

Fluid Evidence

Liquid biopsy can help us appropriately treat patients with anti-PD-L1 immunotherapies, and ddPCR enables ongoing monitoring and adjustment of treatment

Outside the Lab Clinical care

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Inside the Lab Genetics and epigenetics

Decoding Autism on Chromosome 16

| Santhosh Girirajan

Researchers from Penn State examine the 16p11.2 deletion for its role in neurodevelopmental disorders and related phenotypes

Inside the Lab Analytical science

No Label? No Problem!

A new approach, wide-field mid-IR microscopy, can help identify biomarkers and diagnose and classify cancers without the need for labeling

Diagnostics Clinical care

Express Insight into Bladder Cancer

Looking at miRNA expression levels may improve our ability to subtype bladder cancers and provide the most appropriate and effective treatment

Inside the Lab Analytical science

Coming Soon: Third-Wave Diagnostics

| Jason Heikenfeld

The need for continuous and contextual biochemical data is clearer than ever, and enabling technology may be just around the corner

Outside the Lab Bioinformatics

The Economics of Personalized Medicine

| Ilan Danieli

Broad NGS panels work well for cancer screening, but for monitoring, we need tools that are less expensive and more targeted

Inside the Lab Clinical care

A Change of Heart (Genetics)

iPSC-based and genome editing approaches to the study of cardiac channelopathies may be the next step toward personalizing diagnosis and treatment

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register